Contract award
OREXO US INC
CLINICAL DEVELOPMENT OF OX390 (ATIPAMEZOLE) AS AN ?2 AGONIST REVERSAL AGENT FOR HUMAN USE TO COUNTERACT THE SEDATIVE EFFECTS OF XYLAZINE, MEDETOMIDINE, AND OTHER ?2 AGONISTS
- PIID
- 75A50125C00010
- Award key
- CONT_AWD_75A50125C00010_7505_-NONE-_-NONE-
- Recipient UEI
- MN1MPMBCVVD5
- Source as of
- —
Current award value
$11,450,7123
Obligated to date
$11,450,7122
Potential with options
$53,897,2523
- Awarding agency
- Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response
- Contractor
- OREXO US INC
- Place of performance
- Morristown, New Jersey
- Set-aside
- No set-aside used
- Pricing
- Cost Sharing
- Competition
- Full and Open Competition1 offers received
- Period of performance
- Sep 24, 2025 — Dec 31, 2027Through Feb 4, 2032 if all options are exercised
- Benchmark category
- Unclassified
Transaction history
Every action recorded against this award, in the order the government reported them.
| Mod | Action date | Reason | Obligation | Value at action |
|---|---|---|---|---|
| 0 | Sep 24, 2025 | Initial award | $8,450,715.00 | $11,450,712.00 |
| P00001 | Sep 4, 2026 | B | $2,999,997.00 | $11,450,712.00 |
Provenance
Which source record produced each displayed rollup figure.
| Field | Source | File | Retrieved | Parser | Artifact hash |
|---|---|---|---|---|---|
| awarding_agency_id | USAspending.gov | — | Sep 6, 2026 | usaspending_contract_csv@2026.08.2 | a7bd9681f017 |
| contractor_id | USAspending.gov | — | Sep 6, 2026 | usaspending_contract_csv@2026.08.2 | a7bd9681f017 |
| current_award_value | USAspending.gov | — | Sep 6, 2026 | usaspending_contract_csv@2026.08.2 | a7bd9681f017 |
| naics_code | USAspending.gov | — | Sep 6, 2026 | usaspending_contract_csv@2026.08.2 | a7bd9681f017 |
| potential_award_value | USAspending.gov | — | Sep 6, 2026 | usaspending_contract_csv@2026.08.2 | a7bd9681f017 |
| psc_code | USAspending.gov | — | Sep 6, 2026 | usaspending_contract_csv@2026.08.2 | a7bd9681f017 |
| total_obligated | USAspending.gov | — | Sep 6, 2026 | usaspending_contract_csv@2026.08.2 | a7bd9681f017 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.
- 1Rollup values derive from 2 transaction records parsed from USAspending.gov, retrieved Sep 6, 2026 by transform awards@2026.08.1.
- 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
- 3Current and potential award values are taken from the latest reported action, not summed across modifications.